Publications by authors named "Todd A Correll"

Claim this Profile
S
Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on antiretroviral therapy: 48-week results of a phase 3, randomised, open-label, non-inferiority trial.
Jean-Michel Molina, Giuliano Rizzardini, Catherine Orrell, Alejandro Afani, Alexandra Calmy, Todd A Correll

Lancet HIV· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Atazanavir Powder and Ritonavir in HIV-1-Infected Infants and Children From 3 Months to <11 Years of Age: The PRINCE-2 Study.
Mark F Cotton, Afaaf Liberty, Indiana Torres-Escobar, Maria Isabel Gonzalez-Tome, Jurgen Lissens, Todd A Correll

Pediatr Infect Dis J· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Pharmacodynamics of Atazanavir in HIV-1-Infected Children Treated With Atazanavir Powder and Ritonavir: Combined Analysis of the PRINCE-1 and -2 Studies.
Heather Sevinsky, Luna Zaru, Reena Wang, Xiaohui Xu, Cheryl Pikora, Todd A Correll

Pediatr Infect Dis J· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of HIV-related medication errors and associated risk factors in hospitalized patients.
Sonak D Pastakia, Amanda H Corbett, Ralph H Raasch, Sonia Napravnik, Todd A Correll

Ann Pharmacother· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of zygomycosis with posaconazole in a patient with acute myeloid leukemia.
Helen L Leather, Todd A Correll, Christine L Meyer, Ilona M Schmalfuss, John R Wingard

Clin Adv Hematol Oncol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis